Literature DB >> 20382540

In silico directed chemical probing of the adenosine receptor family.

Filipe M Areias1, Jose Brea, Elisabet Gregori-Puigjané, Magdi E A Zaki, M Alice Carvalho, Eduardo Domínguez, Hugo Gutiérrez-de-Terán, M Fernanda Proença, María I Loza, Jordi Mestres.   

Abstract

One of the grand challenges in chemical biology is identifying a small-molecule modulator for each individual function of all human proteins. Instead of targeting one protein at a time, an efficient approach to address this challenge is to target entire protein families by taking advantage of the relatively high levels of chemical promiscuity observed within certain boundaries of sequence phylogeny. We recently developed a computational approach to identifying the potential protein targets of compounds based on their similarity to known bioactive molecules for almost 700 targets. Here, we describe the direct identification of novel antagonists for all four adenosine receptor subtypes by applying our virtual profiling approach to a unique synthesis-driven chemical collection composed of 482 biologically-orphan molecules. These results illustrate the potential role of in silico target profiling to guide efficiently screening campaigns directed to discover new chemical probes for all members of a protein family. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382540     DOI: 10.1016/j.bmc.2010.03.048

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Synthesis, pharmacological evaluation and molecular docking of pyranopyrazole-linked 1,4-dihydropyridines as potent positive inotropes.

Authors:  Rakesh Kumar; Neha Yadav; Rodolfo Lavilla; Daniel Blasi; Jordi Quintana; José Manuel Brea; María Isabel Loza; Jordi Mestres; Mamta Bhandari; Ritu Arora; Rita Kakkar; Ashok K Prasad
Journal:  Mol Divers       Date:  2017-04-25       Impact factor: 2.943

2.  Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1.

Authors:  Edurne Gallastegui; Brett Marshall; David Vidal; Gonzalo Sanchez-Duffhues; Juan A Collado; Carmen Alvarez-Fernández; Neus Luque; Jean-Michel Terme; Josep M Gatell; Sonsoles Sánchez-Palomino; Eduardo Muñoz; Jordi Mestres; Eric Verdin; Albert Jordan
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

Review 3.  Target deconvolution techniques in modern phenotypic profiling.

Authors:  Jiyoun Lee; Matthew Bogyo
Journal:  Curr Opin Chem Biol       Date:  2013-01-18       Impact factor: 8.822

4.  A chemocentric approach to the identification of cancer targets.

Authors:  Beáta Flachner; Zsolt Lörincz; Angelo Carotti; Orazio Nicolotti; Praveena Kuchipudi; Nikita Remez; Ferran Sanz; József Tóvári; Miklós J Szabó; Béla Bertók; Sándor Cseh; Jordi Mestres; György Dormán
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

5.  Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for 'Orphan' Molecules.

Authors:  Michael Reutlinger; Christian P Koch; Daniel Reker; Nickolay Todoroff; Petra Schneider; Tiago Rodrigues; Gisbert Schneider
Journal:  Mol Inform       Date:  2013-02-07       Impact factor: 3.353

6.  Closing the Gap Between Therapeutic Use and Mode of Action in Remedial Herbs.

Authors:  Joaquim Olivés; Jordi Mestres
Journal:  Front Pharmacol       Date:  2019-10-03       Impact factor: 5.810

7.  Prediction of the P. falciparum target space relevant to malaria drug discovery.

Authors:  Andreas Spitzmüller; Jordi Mestres
Journal:  PLoS Comput Biol       Date:  2013-10-17       Impact factor: 4.475

8.  Comparative Study of Carborane- and Phenyl-Modified Adenosine Derivatives as Ligands for the A2A and A3 Adenosine Receptors Based on a Rigid in Silico Docking and Radioligand Replacement Assay.

Authors:  Marian Vincenzi; Katarzyna Bednarska; Zbigniew J Leśnikowski
Journal:  Molecules       Date:  2018-07-25       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.